Sable Bio is a biotechnology company that leverages artificial intelligence to revolutionize drug safety assessments. Their AI-powered platform, Sable Target Intelligence, integrates comprehensive safety data across clinical, genetic, experimental, and literature sources, enabling researchers to systematically evaluate and prioritize toxicology risks. By providing unified and up-to-date safety information, Sable Bio empowers scientists to make faster, more informed decisions, ultimately accelerating the development of safe and effective medicines.